Abstract
Chloroquine-resistant Plasmodium vivax (CRPV) infection is emerging as a clinically significant problem. Detailed travel history is crucial to the management of imported malarial cases. We report a 58-year-old business traveler who returned from Indonesia and experienced relapse due to CRPV. The epidemiology and diagnostic challenges of CRPV for travel medicine clinicians are reviewed.
MeSH terms
-
Antimalarials / administration & dosage*
-
Chloroquine / administration & dosage*
-
Drug Resistance, Microbial
-
Humans
-
Malaria, Vivax / diagnosis
-
Malaria, Vivax / drug therapy*
-
Male
-
Mefloquine / administration & dosage*
-
Middle Aged
-
Plasmodium vivax / drug effects*
-
Plasmodium vivax / isolation & purification
-
Singapore
-
Treatment Outcome
Substances
-
Antimalarials
-
Chloroquine
-
Mefloquine